Cited by 530Multiple Sclerosis Research StudiesPolyomavirus and related diseasesPsoriasis: Treatment and Pathogenesis

Defining high, medium, and low impact prognostic factors for developing multiple sclerosis

Tintore, Mar, Rovira, Àlex, Río, Jordi, Otero-Romero, Susana, Arrambide, Georgina, Tur, Carmen, Comabella, Manuel, Nos, Carlos +11 more·2015·Brain

Abstract

Natural history studies have identified factors that predict evolution to multiple sclerosis or risk of disability accumulation over time. Although these studies are based on large multicentre cohorts with long follow-ups, they have limitations such as lack of standardized protocols, a retrospective data collection or lack of a systematic magnetic resonance imaging acquisition and analysis protocol, often resulting in failure to take magnetic resonance and oligoclonal bands into account as joint covariates in the prediction models. To overcome some of these limitations, the aim of our study was to identify and stratify baseline demographic, clinical, radiological and biological characteristics that might predict multiple sclerosis development and disability accumulation using a multivariate approach based on a large prospective cohort of patients with clinically isolated syndromes. From 1995 to 2013, 1058 patients with clinically isolated syndromes were included. We evaluated the influence of baseline prognostic factors on the risk for developing clinically definite multiple sclerosis, McDonald multiple sclerosis, and disability accumulation (Expanded Disability Status Scale score of 3.0) based on univariate (hazard ratio with 95% confidence intervals) and multivariate (adjusted hazard ratio with 95% confidence intervals) Cox regression models. We ultimately included 1015 patients followed for a mean of 81 (standard deviation = 57) months. Female/male ratio was 2.1. Females e…

Integrity signals

Registry

Crossref · 10.1093/brain/awv105

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies showed that inclusion of symptomatic lesions in the MRI determination of DIS or DIT increases MS diagnostic sensitivity with little or no reduction in specificity.

    “Recent studies showed that inclusion of symptomatic lesions in the MRI determination of DIS or DIT increases MS diagnostic sensitivity with little or no reduction in specificity 70,71 and was proposed in the 2016 MAGNIMS Criteria. 7,72”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tintore, M., Rovira, À., Río, J., Otero-Romero, S., Arrambide, G., Tur, C., Comabella, M., Nos, C., Arévalo, M. J., Negrotto, L., Galán, I., Vidal-Jordana, A., Castilló, J., Palavra, F., Simon, E., Mitjana, R., Auger, C., Sastre-Garriga, J., & Montalban, X.
Affiliations
Universitat Autònoma de Barcelona (ES)
Venue
Brain
Published
2015-04-21
Volume
138
Issue
7
Pages
1863-1874
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2058583207
Cited by
530
References
2
Citations by year
2026: 30 · 2025: 40 · 2024: 51 · 2023: 39 · 2022: 49 · 2021: 60 · 2020: 52 · 2019: 64 · 2018: 55 · 2017: 53 · 2016: 33 · 2015: 3
FWCI
38.09
Type
journal article
Language
en
Open access
closed
Locations
  • Brain (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
clinically isolated syndrome, conversion to multiple sclerosis, disability progression, prognostic factors, oligoclonal bands, brain lesions, magnetic resonance imaging, optic neuritis, disease-modifying therapy, age of onset, sex differences, Expanded Disability Status Scale, McDonald criteria, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, primary progressive multiple sclerosis
MeSH terms
Adult, Brain, Demyelinating Diseases, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Prognosis, Risk Factors, Cohort Studies, Proportional Hazards Models, Disease Progression, Oligoclonal Bands

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review